The cholesterol lowering statins were the top class of pharmaceuticals in terms of sales in the US in 2002. Overall, US pharmaceutical sales grew by 12% to $220 billion. Worldwide, drug sales totalled $430 billion, a growth of 8%. [ bmj.com Gottlieb 326 (7388): 518c ]